Abstract
Irradiated wounds are notorious for poor healing. There are limited options for those who cannot undergo free flap surgeries. NovoSorb® Biodegradable Temporizing Matrix (BTM) is a synthetic bilayer dermal matrix. We present a case of a scalp squamous cell carcinoma (SCC) arising from congenital sebaceous nevus that was initially managed with irradiation. Upon presentation, the wound was ulcerated and infected. BTM was successfully applied and eventually grafted without the patient needing to undergo a more complex surgery.
Keywords: biodegradable temporizing matrix, irradiated wound, scalp reconstruction, case report
Case
Introduction
A 61-year-old female with no significant past medical history presented with a 6-year history of a gradually enlarging lesion on the right parietal scalp, which had recently become ulcerated. On examination, the lesion measured approximately 5 × 5 cm and appeared to arise from a congenital sebaceous naevus (Figure 1A). Biopsy confirmed a moderately differentiated squamous cell carcinoma (SCC) with basaloid and sebaceous differentiation. Clinical examination further revealed palpable right cervical lymph nodes at levels II and Va; however, fine-needle aspiration of these nodes was negative for malignancy. Contrast-enhanced computed tomography of the brain demonstrated a 4.7 × 1.9 × 5.1 cm right parietal lesion with no evidence of skull invasion or aggressive periosteal involvement. Notably, the patient had undergone 15 sessions of radiotherapy (unknown dosage) at a private facility prior to referral to our plastic surgery service.
Figure 1.

Preoperative and intraoperative views of the scalp lesion and surgical defect. (A). Preoperative clinical photograph showing a 5 × 5 cm ulcerated lesion on the right parietal scalp, arising from a congenital sebaceous naevus. (B). Intraoperative view following wide local excision with a 2 cm macroscopic margin, resecting down to the galea and resulting in a 10 × 10 cm defect prior to BTM application
Clinical Reasoning and Treatment Rationale
Wide local excision with clear margins was indicated given the tumor size, location, and history of prior radiotherapy. The parietal scalp poses a reconstructive challenge due to limited tissue laxity and the underlying calvarium, which precludes primary closure, while the irradiated bed further heightens the risk of poor wound healing and graft failure. The patient declined immediate free flap reconstruction until margin clearance was confirmed, and regional or local flap options of this size would have necessitated additional grafting to adjacent scalp areas. Given these constraints and the lesion’s uncertain pathology, NovoSorb® Biodegradable Temporizing Matrix (BTM) was chosen as a temporizing strategy offering a vascularized neodermis over the exposed galea. This converted a complex defect into a graftable surface while mitigating contracture and optimizing contour. There was the added advantage that alternative reconstructive options remain available should revascularization fail. Sentinel lymph node biopsy was performed concurrently for staging purposes, given the palpable regional nodes.
Intervention
In November 2023, the patient underwent wide local excision of the right parietal scalp SCC with a 2 cm macroscopic margin, resecting down to the galea (Figure 1B). The resultant 10 × 10 cm defect was immediately washed with water, and a NovoSorb® BTM was stapled onto the wound to secure it in place. Negative pressure wound therapy (NPWT) was applied at 125 mmHg continuous suction setting and maintained for one week to promote matrix adherence and neovascularization.
Postoperative Course and First-Stage Management
During the integration phase, the wound was assessed daily with dressings changed daily using Bactigras and gauze. The wound was monitored closely for signs of infection, hematoma, or seroma (Figure 2A). Final histopathology confirmed clear resection margins with no perineural or lympho-vascular invasion. The sentinel lymph node biopsy was negative for malignancy, confirming N0 status. The wound was judged ready for the second stage when there were clear signs of revascularization.
Figure 2.

First- and second-stage BTM reconstruction. A. Clinical photograph at 1-week post-BTM application. B. Clinical photograph of second stage reconstruction at postoperative day 40 after application of STSG
Second-Stage Procedure
On postoperative day 40 following adequate vascularization of the BTM, as evidenced by a pink, viable neodermis with capillary refill, and the pathology report confirming adequate tumor clearance, the second stage procedure was performed. The non-biodegradable polyurethane sealing membrane outer layer was delaminated, and a meshed split-thickness skin graft (STSG) harvested from the right thigh was applied over the neodermis. The graft was secured with a tie-over bolster dressing to ensure close contact with the wound bed and prevention of shearing of the graft (Figure 2B).
Outcomes and Follow-Up
STSG demonstrated complete take by postoperative day 10, with no graft loss, hematoma, or infection. The donor site healed uneventfully with conservative wound care. The patient was followed up at 1, 3, 6, 12, and 24 months postoperatively. At each visit, the graft remained fully integrated with excellent color and texture match, and no contour depression or contracture was observed. There was no evidence of local recurrence, regional lymphadenopathy, or distant metastasis throughout the follow-up period, with the patient remaining disease-free at the 24-month mark (Figure 3).
Figure 3.

Long-term follow-up at 24 months postoperatively. Clinical photograph showing no evidence of local recurrence, regional lymphadenopathy, or distant metastasis. The patient remained disease-free at the 24-month mark
Discussion
This case report illustrates the successful use of dermal matrix in a heavily irradiated wound. Radiotherapy is an essential modality in cancer management, but it significantly impairs wound healing and complicates reconstruction. It induces a cascade of cellular and vascular changes including DNA damage, cellular depletion, increased pro-inflammatory mediators, aberrant collagen and fibroblast deposition, endarteritis obliterans and eventually tissue hypoxia. This delays revascularization, reduces tissue compliance and impairs grafts and flaps integration. 1
Skin grafts take in non-irradiated tissue can be as high as 95% whilst in irradiated tissues, the graft take rates can be as low as 50-60%. 2 Therefore, historically, free flap reconstructions have been regarded as the gold standard for managing these defects. Their robust vascularity and ability to fill complex-three-dimensional defects make them ideal choices. 3 Free flap operations, however, are technically demanding and require prolonged operation times. Literature reports flap failure rates are increased to 10% to 20% in irradiated tissues, with higher rates observed in patients with significant comorbidities (e.g. diabetes, cardiovascular disease, low albumin level). 4 These patients also have a 2- to 3-fold increased risk of postoperative complications. 5
Given these challenges, there has been a growing interest in less “risky” operations for irradiated wounds. Recent advances in tissue engineering and regenerative medicine have raised the possibility of using dermal matrix to cover such defects but the results, thus far, have been disappointing. For example, Integra®, one of the earliest dermal matrices available, has reported overall graft take rates exceeding 90%. However, in wounds with preoperative radiotherapy, the revascularisation rate can fall as low as 50%. 6 Its use in already irradiated scalp wounds was strongly discouraged in a systematic review of the literature. 6
NovoSorb® BTM was developed in Royal Adelaide Hospital of Australia in 2004 and first utilized in burns reconstruction in 2013. Its versatility includes the successful use in heavily contaminated wounds, 7 exposed non-graftable wound beds 8 and wounds that have subsequently been irradiated without skin graft loss. 9 It may be particularly advantageous in patients who are poor candidates for free flap reconstruction, including the elderly, those with significant medical comorbidities, and individuals who decline microsurgery. In such populations, BTM offers a less morbid, staged alternative that can achieve wound closure without the physiological demands and technical complexity of microvascular transfer.
We have reviewed all published literature on BTM in oncological reconstruction confirms that it is a safe and effective dermal scaffold for soft tissue defects. Across all cohorts, complete BTM integration rates ranged from 83% to 100%, with successful skin graft take observed in 78% to 100% of cases, underscoring the reproducibility of this technique. In the largest cohort of 54 patients with head and neck malignancies, Conway et al (2025) reported a 92% integration rate with minimal complications. 10 Similarly, Calderbank et al (2025) achieved a 92% integration rate and 100% graft take in elderly patients undergoing scalp reconstruction, further validating its utility in high-risk subsites. 11 Notably, this study also highlighted BTM’s role as an effective salvage therapy, as patients who had previously failed primary STSG subsequently achieved successful take following BTM application, suggesting that the matrix optimizes wound bed vascularity and granulation tissue quality in recalcitrant wounds.
Despite these promising outcomes, certain subpopulations confer increased risk for suboptimal integration. Devine et al. (2024) observed that both failures occurred in patients who had received pre-operative radiotherapy, indicating that prior irradiation may compromise neovascularization and cellular infiltration essential for BTM incorporation. 12 However, our own case achieved complete graft take despite prior undocumented radiotherapy, indicating that irradiation does not invariably preclude success. The overall complication profile was favourable, with infections being generally mild and manageable, and no procedure-related mortality reported. The low incidence of adverse events, coupled with a reduction in mean hospital stay to 1.1 days, positions BTM as a cost-effective intervention that may reduce healthcare burden without compromising outcomes. Beyond oncological applications, BTM has shown promise in functional and aesthetic preservation at critical anatomical sites. Mohan et al (2025) reported successful reconstruction over the ankle joint with maintained mobility. 13 Furthermore, Phoenix et al (2025) described the first single-stage reconstruction of the nail bed using BTM, achieving excellent cosmetic and functional restoration. 14 Although limited to single-patient reports, these cases highlight BTM can be adapted in specialized reconstructive needs, and its procedure can be optimized (Table 1).
Table 1.
Summary of Recent Case Series
| Study | N | Sex (M/F) | Mean age | Pathology | RT History | Time to integration | Integration rate | SSR type | Graft take | Complications (n) | Key findings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Devine et al. 2024 | 12 | 8/4 | 70 | SCC, BCC, melanoma, sarcoma, ORN, EMPD | 5 pre-op, 2 post-op | 49 days | 83% | STSG (100%) | 78% | Infection (3), hematoma (3), delayed healing (1) | Lower integration in irradiated fields; reduced hospital stays (mean 1.1 days) |
| Conway et al. 2025 | 54 | 35/19 | 79 | SCC, BCC, melanoma, AKs, AFX, radio-osteonecrosis | N/A | 51 days | 92% | STSG (68%), FTSG (14%), secondary intention (17%) | 92% | Nonsignificant; 1 unrelated death | Reliable in head/neck reconstruction; 92% success, minimal complications |
| Calderbank et al. 2025 | 12 | 12/0 | 85 | SCC, melanoma | 5 concurrent | 46 days | 92% | STSG (85%); 1 healed without SSR | 100% | Infection (1) | Effective for scalp reconstruction and as salvage after failed STSG |
| Mohan et al. 2025 | 1 | 1/0 | 65 | Spiradenoma | No | 28 days | 100% | STSG | N/A | Mild swelling, donor-site pain | Preserved ankle joint mobility |
| Phoenix et al. 2025 | 1 | 1/0 | 47 | Glomus tumor | No | 42 days | 100% | None | N/A | Mild infection | First single-stage nail bed reconstruction; good functional outcome |
RT: Radiotherapy; SSR: Second Stage Reconstruction; SCC: Squamous Cell Carcinoma; BCC: Basal Cell Carcinoma; ORN: Osteoradionecrosis; EMPD: Extramammary Paget’s Disease; AKs: Actinic Keratoses; AFX: Atypical Fibroxanthoma; STSG: Split-thickness Skin Graft; FTSG: Full-thickness Skin Graft; N/A: Not Available.
Compared with other dermal substrates, BTM offers several notable advantages. Its acellular composition eliminates immune rejection and disease transmission. It also avoids the ethical and cultural barriers. The bilayer synthetic dermal matrix is resistance to infection, and minimizes pathological contracture, thereby preserving functional joint mobility. Critically, BTM provides a vascularized neodermis over structures traditionally deemed non-graftable, such as bone, tendon, and cartilage, making them into graftable surfaces and enabling significantly shortened hospital stays. These properties render it particularly valuable in oncologic and trauma reconstruction. However, limitations include a mandatory two-stage procedure, contraindication in necrotic or actively bleeding tissue (necessitating thorough debridement), and high cost, which combined with staged resource use, limits accessibility and raises cost-effectiveness concerns.
The transformation of a congenital sebaceous nevus into SCC is exceedingly rare with most transforming to basal cell carcinoma. 15 The initial treatment of choice with radiation is unusual as it complicates the reconstruction. Traditional management would have been a large scalp flap or free flap reconstruction which not all patients would tolerate or agree to. This novel use of BTM has demonstrated that there may be alternatives for these patients. Further research is necessary to validate the effectiveness and durability of BTM in similarly irradiated wounds.
Several limitations of this report should be acknowledged. First, as a single case report, the findings require validation through larger case series to better elucidate the impact of preoperative irradiation on BTM integration. Second, the patient received 15 radiotherapy sessions at an external facility, but the precise dosage and fractionation could not be obtained. Therefore, we could not assess the relationship between radiation dose and BTM incorporation. Despite this, the successful application and graft take of BTM in this irradiated, infected wound is clinically significant. Radiation-induced vasculopathy and fibrosis are dose-dependent and typically impair wound healing. That BTM facilitated closure in this hostile setting suggests it may serve as an effective scaffold independent of native vasculature, supporting cellular infiltration and revascularization. However, the lack of dosimetry data precludes correlation between radiation severity and outcome, or definition of a dose threshold for BTM efficacy. Future studies with documented radiotherapy parameters are required to establish dose-specific recommendations. Until then, clinicians should exercise caution when applying BTM in heavily irradiated fields and evaluate individual patient factors. Fourth, aside from clinical examination, no objective oncological follow-up data were available during the 24-month period, precluding comprehensive assessment of disease status and recurrence.
Conclusion
This case report presents a novel application of BTM combined with skin grafting for scalp SCC excision after radiotherapy. The successful outcome highlights BTM’s potential as a promising and effective alternative to traditional flap-based approaches in challenging and radiation-damaged tissues. Further studies are warranted to evaluate its long-term efficacy and applicability in complex reconstructive scenarios.
Authors Contributions: Liu Ka Ying Eunice: Investigation, Writing – Original Draft Preparation. Chiu Tor Wo: Conceptualization, Writing – Review & Editing. Ma Hui: Methodology, Writing – Review & Editing. Ting Wen Ching Jeannette: Conceptualization, Investigation, Writing – Review & Editing.
Funding: The authors received no financial support for the research, authorship, and/or publication of this article.
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Guarantor: Author accepts full responsibility.
ORCID iDs
Hui Ma https://orcid.org/0000-0003-2942-597X
Wen Ching Jeannette Ting https://orcid.org/0000-0003-3931-8246
Consent to Participate
Written informed consent has been obtained from the patients. She consented to the documentation of her case as a case report and the inclusion of the above information in this report. All identifying information has been removed.
References
- 1.Jacobson LK, Johnson MB, Dedhia RD, Niknam-Bienia S, Wong AK. Impaired wound healing after radiation therapy: A systematic review of pathogenesis and treatment. JPRAS Open. 2017;13:92-105. [Internet]. [Google Scholar]
- 2.Kurul S, Dinçer M, Kizir A, Uzunismail A, Darendeliler E. Plastic surgery in irradiated areas: analysis of 200 consecutive cases. Eur J Surg Oncol. 1997;23(1):48-53. [DOI] [PubMed] [Google Scholar]
- 3.Fujioka M. Surgical Reconstruction of Radiation Injuries. Adv Wound Care. 2014;3(1):25-37. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Spoerl S, Schoedel S, Spanier G, et al. A decade of reconstructive surgery: outcome and perspectives of free tissue transfer in the head and neck. Experience of a single center institution. Oral Maxillofac Surg. 2020;24(2):173-179. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Lese I, Biedermann R, Constantinescu M, Grobbelaar AO, Olariu R. Predicting risk factors that lead to free flap failure and vascular compromise: A single unit experience with 565 free tissue transfers. J Plast Reconstr Aesthet Surg. 2021;74(3):512-522. [DOI] [PubMed] [Google Scholar]
- 6.Johnson MB, Wong AK. Integra-based Reconstruction of Large Scalp Wounds. Plast Reconstr Surg Glob Open. 2016;4(10):e1074. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Fruergaard O, Ørholt M, Lyngsaa Lang C, et al. A systematic review of the Novosorb® Biodegradable Temporizing Matrix in the treatment of complex wounds. Burns Open. 2025;9:100378. [Google Scholar]
- 8.Tam SSC, Taylor K, Patel P, Goon P, Khatib M. Case Series of Reconstruction Applying NovoSorb Biodegradable Temporising Matrix: Preliminary Practice and Findings in the United Kingdom. Eplasty. 2025;25:e20. [PMC free article] [PubMed] [Google Scholar]
- 9.Sun L, Cox S, Ek T. Radiotherapy for wound treated with BTM: a case report and review of literature. Innov Tissue Eng Regen Med. 2021;1(4). [Google Scholar]
- 10.Conway L, Snashall E, Gill P, Harper-Machin A. The Use of Novosorb Biodegradable Temporizing Matrix for Reconstruction in Head and Neck Cancer: A Simple Answer to a Complex Problem. Plast Reconstr Surg Glob Open. 2025;13(4):e6702. doi: 10.1097/GOX.0000000000006702. Published 2025 Apr 29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Calderbank T, Turner E, Mohamed M, Kanakopoulos D, Kelemen N. Biodegradable Temporizing Matrix in Postoncological Scalp Reconstruction: A Case Series. Plast Reconstr Surg Glob Open. 2025;13(1):e6497. doi: 10.1097/GOX.0000000000006497. Published 2025 Jan 28. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Devine M, Edmondson M, Gearing P, et al. NovoSorb® biodegradable temporising matrix (BTM) in the reconstruction of cutaneous malignancies in a major cancer centre: a case series. ANZ J Surg. 2024;94(9):1518-1523. [DOI] [PubMed] [Google Scholar]
- 13.Mohan N, Pang A, Griswold JA. Biodegradable temporizing matrix in small-scale reconstruction of malignant resections in functional areas. Proc (Bayl Univ Med Cent). 2025;39(3):513-515. doi: 10.1080/08998280.2025.2583854. Published 2025 Nov 21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Phoenix E, Carolan D, Caird R, Ibrahim S. Single stage reconstruction of the right thumbnail with Novosorb® Biodegradable Temporizing Matrix (BTM) following massive glomus tumor resection. JPRAS Open. 2025;48:315-320. doi: 10.1016/j.jpra.2025.11.003. Published 2025 Nov 6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Cribier B, Scrivener Y, Grosshans E. Tumors arising in nevus sebaceus: A study of 596 cases. J Am Acad Dermatol. 2000;42(2):263-268. [DOI] [PubMed] [Google Scholar]
